FDA Approves Use of Linzess (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC)

May 28, 2026 - 10:00
 0  0
BOSTON--(BUSINESS WIRE) May 27, 2026 -- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life changing therapies for people living with gastrointestinal (GI) and rare diseases, today announced...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0